April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Predictors for Visual Outcome Prior to Anti-VEGF Therapy in Vascular Occlusive Diseases
Author Affiliations & Notes
  • U. E. Wolf-Schnurrbusch
    Universitatsklinik fur Augenheilkunde, University of Bern, Bern, Switzerland
  • C. Framme
    Universitatsklinik fur Augenheilkunde, University of Bern, Bern, Switzerland
  • S. P. Rothenbuehler
    Universitatsklinik für Augenheilkunde, Bern Photographic Reading Center, Bern, Switzerland
  • S. Wolf
    Universitatsklinik fur Augenheilkunde, University of Bern, Bern, Switzerland
  • Footnotes
    Commercial Relationships  U.E. Wolf-Schnurrbusch, None; C. Framme, None; S.P. Rothenbuehler, None; S. Wolf, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4379. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      U. E. Wolf-Schnurrbusch, C. Framme, S. P. Rothenbuehler, S. Wolf; Predictors for Visual Outcome Prior to Anti-VEGF Therapy in Vascular Occlusive Diseases. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4379.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : With high resolution SD-OCT it’s possible to distinguish the outer retina layer with the external limiting membrane (ELM), the inner/outer segment junction, and the RPE very well. Purpose of our study was to identify features as predictors for favorable visual outcome prior to Anti-VEGF therapy in patients with clinical significant macular edema (CSME) due to Central Retinal Vein Occlusion (CRVO) and Branch Retinal Vein Occlusion (BRVO).

Methods: : Patients with CSME due to CRVO and BRVO were examined at BL (best corrected visual acuity (BCVA), biomicroscopy, fluorescein angiography and Spectralis HRA+OCT). If both eyes were eligible, one was randomly chosen as the study eye. Patients with intact ELM in the SL-OCT images were included into group 1, whereas patients with disturbances in the ELM were included into group 2. In addition size and configuration of cystoid spaces were analysed. BCVA was analysed 4 weeks after the initial intravitreal anti-VEGF therapy in respect to the layer integrity and to findings like the configuration, size and localisation of the cystoid spaces.

Results: : BRVO (n= 52): We distributed 28 eyes with BRVO to group 1 and 24 eyes to group 2. On average patients with intact ELM experienced a gain in BCVA of 8±3 letters, but patients with disturbances in ELM gained only 2±3 letters. CRVO (n= 32): We distribute 17 eyes with CRVO to group 1 and 15 eyes to group 2. On average the patients with the intact ELM experienced a visual gain of 7±4 letters, but patients with disturbants in ELM gained only 2±1 letters. The size of cystoid spaces was not related to BCVA, but there are differences regarding the configuration of those cystoid spaces.

Conclusions: : Analysis of SD-OCT provides predictors for BCVA in patients with vascular occlusive diseases for a better selection prior to therapy.

Clinical Trial: : www.clinicaltrials.gov NCT00564291

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • retina • vascular occlusion/vascular occlusive disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×